By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Merrimack Pharmaceuticals Inc. 

101 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-441-1000 Fax: 617-491-1386


SEARCH JOBS



Segment
Start Up

Collaborations

Dyax Corp.  Antibody phage display





Company News
Merrimack Pharmaceuticals Inc. (MACK) Names Birgit M. Schoeberl, Ph.D. As Head Of Discovery Division And Announces The Addition Of Ulrik B. Nielsen, Ph.D. To Its Board Of Directors 1/23/2015 7:39:11 AM
Merrimack Pharmaceuticals Inc. (MACK) Presents Additional Analyses Of Phase 3 MM-398 NAPOLI-1 Study At The American Society of Clinical Oncology 2015 Gastrointestinal Cancers Symposium 1/20/2015 6:53:46 AM
Merrimack Pharmaceuticals Inc. (MACK) Announces Oral Presentation Of Additional Analyses Of MM-398 Phase 3 NAPOLI-1 Study At The American Society of Clinical Oncology 2015 Gastrointestinal Cancers Symposium 1/8/2015 7:50:22 AM
Merrimack Pharmaceuticals Inc. (MACK) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/7/2015 10:06:04 AM
Merrimack Pharmaceuticals Inc. (MACK) Announces The Addition Of Russell T. Ray To Its Board Of Directors 12/17/2014 8:01:49 AM
Merrimack Pharmaceuticals Inc. (MACK) Presents Research On Innovative Pipeline For Patients With Breast Cancer At The 2014 San Antonio Breast Cancer Symposium 12/12/2014 7:33:29 AM
Merrimack Pharmaceuticals Inc. (MACK) To Present At Oppenheimer 25th Annual Healthcare Conference, Hold Analyst Day And Present Research On Multiple Molecules In December 2014 12/3/2014 4:01:30 PM
Merrimack Pharmaceuticals Inc. (MACK) Presents On Multiple Programs At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium On Molecular Targets And Cancer Therapeutics 11/21/2014 2:46:31 PM
PharmaEngine Announces The Receipt Of US FDA Fast Track Designation For MM-398 In Post-Gemcitabine Metastatic Pancreatic Cancer By Merrimack Pharmaceuticals Inc. (MACK) 11/20/2014 5:53:40 AM
Merrimack Pharmaceuticals Inc. (MACK) Receives FDA Fast Track Designation For MM-398 In Post-Gemcitabine Metastatic Pancreatic Cancer 11/19/2014 9:22:59 AM
12345678910...
//-->